Posts in Michelle Hoffmann Posts
New White Paper: A Rare-Disease Approach to Seizure Treatment
Back Bay Report on Neoantigen-Based Cancer Immunotherapy
Blog, Jonathan Gertler Posts, Michelle Hoffmann Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsASCO, Cancer, CART-T, immuno-oncology, Neoantigens, Oncology, T Cell, White Paper
STAT: Biosimilars, The Cure for Sky-High Drug Prices or a Stake in the Heart of Innovation?
Back Bay Life Science Advisors to Lead BioNetwork West Partnering Summit October 23-25
Pharma Letter: Rare Disease Drug Development
Healthcare Innovation News: Building a Culture of Innovation
Positive Prognosis for The 21st Century Cures Act
